Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: Tender for the supply of pharmaceuticals containing the active ingredient Bimekizumab (ATC: L04AC21) issued by AOK Sachsen-Anhalt in Magdeburg, Germany. The contract will commence on January 1, 2027, and has a maximum duration of 24 months, ending on December 31, 2028.
Scope Of Work: The tender involves the establishment of non-exclusive discount contracts for finished pharmaceuticals containing Bimekizumab under an 'open-house model'. Pharmaceutical companies can request participation documents to enter into discount agreements as per § 130a Abs. 8 SGB V. Contracts can be signed at any time without exclusivity, and individual negotiations will not be conducted. The earliest contract start date is January 1, 2027, with a maximum contract duration of 24 months.
Qualification Criterion: Eligible bidders must be pharmaceutical companies that can provide the requested participation documents fully completed and signed. There are no exclusivity requirements, and contracts are available to all qualifying pharmaceutical entities. The tender does not involve public procurement under § 103 GWB and is published for transparency.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| University of Cologne - Preparation and Advice on It-Grundschutz Certificate | Germany | 152615553 | 17 Dec 2026 |
| Cleaning and Care Products, Kitchen and Cleaning Consumables, First Aid Items, Disinfectant Gel | Germany | 152615047 | 21 Dec 2026 |
| Group 18-26 Lot 1 | Germany | 152614556 | 19 Jan 2027 |
| Hybrid - the Incubator | Germany | 152611923 | 18 Dec 2026 |
| Point Dendrometer | Germany | 152610261 | 02 Dec 2026 |